Product NDC: | 14783-062 |
Proprietary Name: | LBel |
Non Proprietary Name: | Ensulizole, Octinoxate, and Oxybenzone |
Active Ingredient(s): | .15; .38; .31 g/5mL; g/5mL; g/5mL & nbsp; Ensulizole, Octinoxate, and Oxybenzone |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 14783-062 |
Labeler Name: | VENTURA INTERNATIONAL LTD., |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20100815 |
Package NDC: | 14783-062-51 |
Package Description: | 1 JAR in 1 BOX (14783-062-51) > 5 mL in 1 JAR (14783-062-52) |
NDC Code | 14783-062-51 |
Proprietary Name | LBel |
Package Description | 1 JAR in 1 BOX (14783-062-51) > 5 mL in 1 JAR (14783-062-52) |
Product NDC | 14783-062 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Ensulizole, Octinoxate, and Oxybenzone |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100815 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | VENTURA INTERNATIONAL LTD., |
Substance Name | ENSULIZOLE; OCTINOXATE; OXYBENZONE |
Strength Number | .15; .38; .31 |
Strength Unit | g/5mL; g/5mL; g/5mL |
Pharmaceutical Classes |